SNX7
SNX7 is a Cyclin-Dependent Kinase Inhibitor (CDKI) pathway inhibitor. SNX7 can be used for research of senescence-related and other CDKI-related diseases[1].
Product Specifications
CAS Number
[685097-43-2]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/snx7.html
Purity
99.89
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CCN1C2=C(C=CC=C2)N=C1/C=C/C3=CC=CO3
Molecular Formula
C15H14N2O
Molecular Weight
238.28
References & Citations
[1]Bey-Dih Chang, et al. Cdki pathway inhibitors and uses thereof. Patent. US20090281129.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC204691L4V 200 µL
Macrophage Inflammatory Protein 3 alpha (CCL20) (NM_004591) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 
